Navigation Links
Lilly Announces Senior Leadership Change

INDIANAPOLIS, Jan. 30 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Enrique Conterno, currently senior vice president of health care professional markets for Lilly in the U.S., has been promoted to president, Lilly USA, LLC. Conterno will succeed Deirdre Connelly, who has led Lilly's U.S. operations since 2005. Connelly has resigned from the company to pursue other opportunities.

Conterno joined Lilly as a sales representative in 1992. From 1993 to 1995, he held roles as a financial analyst, marketing associate, and business development manager. In 1996, Conterno became sales and marketing director for Lilly's Peru affiliate, and in 1998 he assumed the same role for Lilly Brazil. In 2000, Conterno was named executive director of marketing for Lilly's intercontinental region (all international markets except for Europe and Japan). In 2003, Conterno became general manager of Lilly Mexico, and in 2006 he was promoted to vice president of Lilly's neuroscience business unit in the U.S. He then assumed his current role in June 2008.

Born in Lima, Peru, Conterno received a master's of business administration degree from Duke University in 1992. He also holds a bachelor's degree in mechanical engineering from Case Western Reserve University that he received in 1989.

"Enrique brings more than 16 years of proven results and strong leadership to one of the company's most important positions," said John Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer. "He understands the complexities of the U.S. marketplace, he has stressed the need to accelerate the transformation that is underway at this company, and he is focused on the needs of the patients we serve. I am pleased that Enrique has accepted this challenge and am confident that he will succeed in this key leadership role. "

Conterno will report to Bryce Carmine, executive vice president of global marketing and sales. He will join the company's operations committee, and will remain a member of the senior management council. Conterno will assume his new role immediately.

Deirdre Connelly, former president of Lilly USA, LLC, has resigned from the company effective immediately to pursue other career interests.

Said Lechleiter, "We regret that Deirdre has decided to leave Lilly. Her passion for the patients we serve will be greatly missed. She has delivered strong results in every role she has held at Lilly. She has displayed a remarkable level of energy and integrity, and she has built a team and a culture that have proven to be successful. We wish her all the best in her future endeavors. Enrique Conterno, I am confident, will build further on the foundation Deirdre and her team have established."

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at

(Logo: )


SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lilly Reports Fourth-Quarter and Full-Year 2008 Results
2. NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lillys Inspired by Diabetes Campaign
3. Law Firm Freedland Russo Spearheads Record-Setting Whistleblower Case Against Pharmaceutical Giant Eli Lilly -- Firm Expands Offices to Include L.A. Entertainment Branch
4. Lilly to Sponsor Martin Luther King Day I AM CHANGE Campaign as Part of Inaugural Gift to President-Elect Obama
5. Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices
6. Whistleblowers Complaints Lead Eli Lilly to Pay $800 Million to Settle Civil Medicaid Fraud Charges, According to Berg & Androphy
7. Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa
8. Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
9. Lilly Files Form 8-K/A Detailing Pro Forma Impact of ImClone Acquisition
10. Lilly Sets Date and Conference Call for Fourth-Quarter and Full-Year 2008 Financial Results Announcement
11. Lilly Announces Dividend Increase
Post Your Comments:
(Date:11/24/2015)... Los Angeles, CA (PRWEB) , ... November 24, 2015 , ... ... author explored the different restrictions and variables that determine which patients are or are ... are those patients that have a BMI over 40, are more than 100 pounds ...
(Date:11/24/2015)... Church, VA (PRWEB) , ... November 24, 2015 , ... ... — 1:30 p.m. – 3:00 p.m. EST, , FDA has long ... regulations. CLIA regulations apply to performing the tests and do not meet the device ...
(Date:11/24/2015)... ... November 24, 2015 , ... In response to recent news highlighting Oxycodone ... prescription opioids in the United States grew 400 percent between 1999 and 2010, far ... involved in 37 percent of all fatal drug overdoses. (1) , While oxycodone and ...
(Date:11/24/2015)... ... November 24, 2015 , ... American Family Care (AFC), the nation’s leading provider ... pop-up clinic located in Metro Atlanta’s North Point Mall. The clinic is designed to ... The location is scheduled to operate through Dec. 24. , Holiday Pop-Up Clinic , ...
(Date:11/24/2015)... Irvine, CA (PRWEB) , ... November 24, 2015 , ... Cold Shoulder , LLC ... Kickstarter last week and hit their goal of $20,000 in under 10 hours. ... aims to bring the new PRO Weight Loss Vest to the market. , The ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... NEW DELHI , November 25, 2015 ... fear invoked due to repeated failure of IVF cycles. ... Rani Bhatia was totally dejected and had lost all hopes that ... the first Indian miracle child conceived after failure of ... to abroad (UK) before they decided to take one last ...
(Date:11/24/2015)... 2015  In the pharmaceutical industry, companies want to ... quickly uncover new insights, tactics and strategies that will ... --> However, organizations often find it is ... ensure that all rules and regulations are met to ... barrier to efficiently launching market research projects is the ...
(Date:11/24/2015)... 2015 --> --> ... Market by Product Type (Bone Graft, Bine Graft Substitute, Platelet ... Posterior Lumbar Interbody Fusion), End User, and Geography - Global ... valued at $1.90 Billion in 2014 and is expected to ... during the forecast period of 2015 to 2020. ...
Breaking Medicine Technology: